119th Congress · introduced in the House · Feb 4, 2026
PASTEUR Act of 2026
Official title from Congress.gov
Latest action (Feb 4, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
34 citations; showing the 25 most recently posted.
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…ng Act H.R. 6945/S. 4242, Supporting Pregnant and Parenting Women and Families Act H.R. 7092/S. 4061, Raising Awareness for Youth Suicide (RAYS) Prevention Act H.R. 7352/S. 4875, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act H.R. 7567, Farm, Food, and National Security Act of 2026 H.R. 7757, K…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CORMEDIX INC. · lobbying firm or registrant: CORMEDIX INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 21, 2026 · issue area: Health Issues
$200,000
Spent on own lobbying
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
…ations ---Value-Based Contracting and Communications ---Value-Based Purchasing (VBP) Rule Vaccines and Infectious Diseases ---H.R.5509/S.2903: SAFE STEP Act ---H.R.7352/S.4875: PASTEUR Act of 2026 ---H.R.9418: Access to Innovative Treatments Act of 2026 ---H.R.9672: Vaccine Injury Compensation Modernization Act of 2026 ---Adul…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medical/Disease Research/Clinical Labs
$2,560,000
Spent on own lobbying
…Funding for Medical Countermeasures ---Reauthorization of Pandemic and All-Hazards Preparedness and Advancing (PAHPA) ---VICP/CICP Antimicrobial Resistance ---H.R.7352/S.4875: PASTEUR Act of 2026 Biodefense Research, Development and Procurement Issues ---Medical Countermeasure Priority Review Voucher Reauthorization CDC Refor…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CYSTIC FIBROSIS FOUNDATION · lobbying firm or registrant: CYSTIC FIBROSIS FOUNDATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$170,000
Spent on own lobbying
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CYSTIC FIBROSIS FOUNDATION · lobbying firm or registrant: CYSTIC FIBROSIS FOUNDATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$170,000
Spent on own lobbying
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS, LLC · lobbying firm or registrant: DH DIAGNOSTICS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$310,000
Spent on own lobbying
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$50,000
Spent on own lobbying
…stance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act); PAMA reform: RESULTS Act (H.R. 5269 S.2761); PASTEUR Act (H.R. 7352 and S. 4875); SUPER BUGS Act (H.R. 7879), and Stop Superbugs Act (S.5237).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL HEALTH COUNCIL · lobbying firm or registrant: NATIONAL HEALTH COUNCIL
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$21,227
Spent on own lobbying
…ricing and Health Coverage H.R. 9599 SECURE 340B Act Discussion Draft - 340B Drug Pricing Integrity and Affordability for Patients Act S. 5244 SUSTAIN 340B Act H.R.7352/S. 4875 PASTEUR Act S.3267/H.R. 6130 ASAP Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR AGING RESEARCH · lobbying firm or registrant: ALLIANCE FOR AGING RESEARCH
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$65,000
Spent on own lobbying
…rtic Valve Replacement -Update CMS Long stay antipsychotic Quality measure -Update FDA Antipsychotic black box warning -Funding for NIH (HR 9260) -PASTEUR Act (HR 7352/S 4975) -Biosimilar Access and Affordability Act (HR10628/S5571) -CMS Fixed Dose Combination Therapies proposed policy -OMB Proposed Uniform Guidance on Federa…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSN. OF STATE AND TERRITORIAL HEALTH OFFICIALS · lobbying firm or registrant: ASSN. OF STATE AND TERRITORIAL HEALTH OFFICIALS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$45,745
Spent on own lobbying
S. 380/H.R. 1254 - Rural Obstetrics Readiness Act S. 4875/H.R. 7352 - PASTEUR Act of 2026 Reauthorization of the Pandemic and All-Hazards Preparedness Act Tobacco Control Public Health Infrastructure Healthy People 2030 Objecti…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medical/Disease Research/Clinical Labs
$50,000
Paid to lobbying firm
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS LLC · lobbying firm or registrant: TIBER CREEK GROUP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$70,000
Paid to lobbying firm
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to infectious disease diagnostics.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS LLC · lobbying firm or registrant: TIBER CREEK GROUP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$70,000
Paid to lobbying firm
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: LEWIS-BURKE ASSOCIATES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 9, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
S. 5237, Stop Superbugs Act, Issues pertaining to NIAID grantmaking for antibiotic-resistant infection research. H.R. 7352, S. 4875, PASTEUR Act, Issues pertaining to antimicrobial drug development. H.R. 766, SEWER Act, Issues pertaining to CDC wastewater surveillance activities. S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 7, 2026 · issue area: Medical/Disease Research/Clinical Labs
$290,000
Spent on own lobbying
…re diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (H.R.7352/S.4875 119th Congress),Administration Executive Orders regarding HHS, NIH, HRSA, FDA, and CDC, Public Health and Bio-Preparedness Workforce Loan Repayment Reau…
Congress stated in the filing; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 7, 2026 · issue area: Health Issues
$290,000
Spent on own lobbying
…and Conrad 30 issues, H-1B Visa issues, 2026 CMS practice expense final rule, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR)(H.R. 7352/S.4875, upcoming legislation on CMS practice expense cuts, 2027 CMS Medicare Physician Fee Schedule proposed rule, H.R. 9693, Patients First Act
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CORMEDIX INC. · lobbying firm or registrant: CORMEDIX INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 31, 2026 · issue area: Health Issues
$220,000
Spent on own lobbying
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CYSTIC FIBROSIS FOUNDATION · lobbying firm or registrant: CYSTIC FIBROSIS FOUNDATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$270,000
Spent on own lobbying
…THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CYSTIC FIBROSIS FOUNDATION · lobbying firm or registrant: CYSTIC FIBROSIS FOUNDATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$270,000
Spent on own lobbying
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS, LLC · lobbying firm or registrant: DH DIAGNOSTICS LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$220,000
Spent on own lobbying
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS LLC · lobbying firm or registrant: TIBER CREEK GROUP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Medicare/Medicaid
$70,000
Paid to lobbying firm
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DH DIAGNOSTICS LLC · lobbying firm or registrant: TIBER CREEK GROUP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Health Issues
$70,000
Paid to lobbying firm
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Medical/Disease Research/Clinical Labs
$50,000
Paid to lobbying firm
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Health Issues
$50,000
Spent on own lobbying
…stance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act); PAMA reform: RESULTS Act (H.R. 5269 S.2761); PASTEUR Act (H.R. 7352 and S. 4875); SUPER BUGS Act (H.R. 7879).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing